花园生物
(300401)
| 流通市值：75.93亿 | | | 总市值：77.17亿 |
| 流通股本：5.35亿 | | | 总股本：5.43亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,243,283,228.76 | 937,594,175.86 | 600,172,551.54 | 330,273,302.02 |
| 营业收入 | 1,243,283,228.76 | 937,594,175.86 | 600,172,551.54 | 330,273,302.02 |
| 二、营业总成本 | 952,332,834.6 | 715,840,066.86 | 478,577,762.2 | 260,819,419.2 |
| 营业成本 | 516,751,694.83 | 392,198,511.26 | 256,043,644.53 | 137,543,476.56 |
| 税金及附加 | 23,072,483 | 14,171,596.61 | 10,742,863.52 | 2,478,970.09 |
| 销售费用 | 193,576,190.68 | 155,333,590.49 | 107,473,005.41 | 64,580,483.39 |
| 管理费用 | 115,796,934.93 | 75,536,883.45 | 53,181,235.55 | 28,131,533.16 |
| 研发费用 | 83,778,120.03 | 59,691,953 | 41,046,604.07 | 20,557,191.99 |
| 财务费用 | 19,357,411.13 | 18,907,532.05 | 10,090,409.12 | 7,527,764.01 |
| 其中:利息费用 | 35,634,971.23 | 28,140,264.6 | 19,326,387 | 10,225,595.56 |
| 其中:利息收入 | 10,291,003.7 | 8,105,533.59 | 5,926,480.86 | 1,166,639.43 |
| 加:公允价值变动收益 | 245,210.96 | - | - | - |
| 加:投资收益 | 716,902.82 | 535,219.09 | 313,047.8 | 140,135.52 |
| 资产处置收益 | 31,530,438.85 | 31,623,354.74 | 31,736,406.76 | 31,380,497.72 |
| 资产减值损失(新) | -2,505,142.09 | 491,098.25 | 491,098.25 | 4,098.58 |
| 信用减值损失(新) | -1,974,128.16 | -3,042,912.76 | -873,891 | -1,193,617.73 |
| 其他收益 | 36,435,671.31 | 20,736,766.04 | 9,156,476.89 | 4,376,648.89 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 355,399,347.85 | 272,097,634.36 | 162,417,928.04 | 104,161,645.8 |
| 加:营业外收入 | 4,232,319.77 | 1,731,336.91 | 639,787.14 | 549,234.08 |
| 减:营业外支出 | 938,247.5 | 570,622.87 | 521,708.38 | 100,143.1 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 358,693,420.12 | 273,258,348.4 | 162,536,006.8 | 104,610,736.78 |
| 减:所得税费用 | 49,484,432.1 | 31,790,531.76 | 20,422,168.02 | 13,127,645.06 |
| 六、净利润 | 309,208,988.02 | 241,467,816.64 | 142,113,838.78 | 91,483,091.72 |
| 持续经营净利润 | 309,208,988.02 | 241,467,816.64 | 142,113,838.78 | - |
| 终止经营净利润 | - | - | - | 91,483,091.72 |
| 归属于母公司股东的净利润 | 309,212,798.15 | 241,469,851.67 | 142,114,009.14 | 91,483,091.72 |
| 少数股东损益 | -3,810.13 | -2,035.03 | -170.36 | - |
| (一)基本每股收益 | 0.57 | 0.45 | 0.26 | 0.17 |
| (二)稀释每股收益 | 0.52 | 0.4 | 0.23 | 0.15 |
| 九、综合收益总额 | 309,208,988.02 | 241,467,816.64 | 142,113,838.78 | 91,483,091.72 |
| 归属于母公司股东的综合收益总额 | 309,212,798.15 | 241,469,851.67 | 142,114,009.14 | 91,483,091.72 |
| 归属于少数股东的综合收益总额 | -3,810.13 | -2,035.03 | -170.36 | - |
| 公告日期 | 2025-03-25 | 2024-10-18 | 2024-08-24 | 2024-04-16 |
| 审计意见(境内) | 标准无保留意见 | | | |